BioCity Biopharma Overview
- Year Founded
-
2017
- Status
-
Private
- Latest Deal Type
-
Series B
- Investors
-
9
BioCity Biopharma General Information
Description
Developer of innovative pharmaceutical drugs designed to address unmet clinical needs in oncology and nephrology. The company offers differentiated drug discovery programs, clinical-stage development capabilities, and translational research integration, enabling global healthcare systems and patients to access targeted therapeutic options and improved treatment outcomes.
Contact Information
Website
www.biocitypharma.comCorporate Office
- 24th Floor, West Building, Huichuang Building
- Number 581 Jianzhu West Road, Binhu District
- Wuxi, Jiangsu 214026
- China
Corporate Office
- 24th Floor, West Building, Huichuang Building
- Number 581 Jianzhu West Road, Binhu District
- Wuxi, Jiangsu 214026
- China
BioCity Biopharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series B) | 27-Apr-2026 | Completed | Clinical Trials - General | |||
| 5. Later Stage VC (Series A2) | 28-Jan-2026 | Completed | Clinical Trials - General | |||
| 4. Secondary Transaction - Private | 02-Apr-2025 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC (Series A1) | 31-Jul-2024 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series A) | 25-Oct-2020 | Completed | Clinical Trials - General | |||
| 1. Early Stage VC | 29-Jul-2020 | $63.5M | Completed | Clinical Trials - General |
BioCity Biopharma Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FirstLight Capital (Beijing) | PE/Buyout | Minority | ||
| Simcere Pharmaceutical Group | Corporation | Minority | ||
| Vivo Capital | Venture Capital | Minority | ||
| Beijing Greatnumbers Asset Management Company | Growth/Expansion | Minority | ||
| Guolian Investment | Corporate Venture Capital | Minority |
BioCity Biopharma FAQs
-
When was BioCity Biopharma founded?
BioCity Biopharma was founded in 2017.
-
Where is BioCity Biopharma headquartered?
BioCity Biopharma is headquartered in Wuxi, China.
-
What industry is BioCity Biopharma in?
BioCity Biopharma’s primary industry is Drug Discovery.
-
Is BioCity Biopharma a private or public company?
BioCity Biopharma is a Private company.
-
What is BioCity Biopharma’s current revenue?
The current revenue for BioCity Biopharma is .
-
Who are BioCity Biopharma’s investors?
FirstLight Capital (Beijing), Simcere Pharmaceutical Group, Vivo Capital, Beijing Greatnumbers Asset Management Company, and Guolian Investment are 5 of 9 investors who have invested in BioCity Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process